Neuroimaging During Pure Oxygen Breathing

Status Completed

Clinical Trial Summary

The investigators will conduct a non-randomized clinical trial to examine the effect of pure oxygen breathing on the brain. The study will compare cerebral blood flow, cortical electrical activity, and cognitive performance in 32 persons during room air (21% oxygen) breathing and pure oxygen (100% oxygen) breathing. Subjects will be used as their own controls. The investigators aim to:

1. Determine whether breathing 100% oxygen changes blood flow through the brain. The investigators will learn whether brain blood flow is increased, decreased or stays the same.

2. Determine if changes that might occur in brain blood flow are also accompanied by changes in the brain's electrical activity (EEG).

3. Learn whether changes in the speed at which the brain processes information (cognitive function) accompany changes in brain blood flow and electrical activity that may be seen.

Clinical Trial Description

The investigators will conduct a crossover design clinical trial to compare the effect of room air breathing (21% inspired oxygen) with pure oxygen breathing (100% inspired oxygen) on brain blood flow and cortical electrical activity. The study involves a one-time data collection taking place at University Hospitals Cleveland Medical Center on the Case Western Reserve University campus in Cleveland, Ohio. The investigators will perform neuroimaging (MRI) with electroencephalographic (EEG) cortical network mapping and cognitive assessments in all participants during room air breathing and again while breathing 100% pure oxygen. Oxygen will be delivered through a non-rebreather mask. Arterial blood partial pressure of oxygen (PaO2) will be measured twice, from arterial blood samples drawn during breathing room air prior to the MRI scan and again after 30 minutes of breathing 100% oxygen immediately following neuroimaging. Thus, the investigators will be able to determine if breathing pure oxygen may temporarily change brain blood flow and breathing, leading to changes in cognitive status such as euphoria or slowed reflexes. Information gained in this study may have direct operational relevance by helping us to understand one potential cause of "Unexplained Physiologic Events" that are reported in some aircraft pilots when flying at high altitude. Information gained could lead to development of new gas mixtures for use by personnel working in low oxygen high altitude environments. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03268590
Study type	Interventional
Source	Case Western Reserve University
Contact
Status	Completed
Phase	Phase 4
Start date	October 2, 2017
Completion date	May 9, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04291911` - Retrospective Multicentre Observational Study on the Incidence of Hyperoxia in Non-intubated Patients in Intensive Care in Belgium Study OxSIZgen
Completed	`NCT02917668` - Evaluation of the Risk of Hyperoxia-induced Hypercapnia in Obese Cardiac Surgery Patients	N/A
Not yet recruiting	`NCT02201875` - Intrinsic Periodic Pattern of Breathing	N/A
Completed	`NCT05770583` - The Effectiveness of FiO2 Titration Guided by the Oxygen Reserve Index in Preventing Hyperoxia.	N/A
Not yet recruiting	`NCT02553668` - Proteomics for Identification of Hyperoxia-induced Changes in Protein Expression	N/A
Completed	`NCT01978158` - Effects of Oxygen Status on Endotoxemia Induced Inflammation and Hypoxia Inducible Factor-1α	Phase 1/Phase 2
Active, not recruiting	`NCT04133740` - Oxygenation Targets in Cardiac Surgery Patients - a Before-and-after Study	Phase 4
Recruiting	`NCT04866342` - Servo Controlled Oxygen Targeting (SCO2T) Study: Masimo vs. Nellcor	N/A
Completed	`NCT05150418` - Supplemental Oxygen in Hypovolemia	Phase 1
Terminated	`NCT03550469` - Computer-assisted Oxygen Therapy Weaning in Critically Ill Children	N/A
Recruiting	`NCT04413097` - Delayed Cord Clamping With Oxygen In Extremely Low Gestation Infants	N/A
Completed	`NCT03464695` - Automated Oxygen Delivery by O2matic to Patients Admitted With an Exacerbation in COPD	N/A
Recruiting	`NCT04269161` - NICU Oxygen Control Study	N/A
Completed	`NCT02384616` - Hyperoxygenation in Anesthetized Children	N/A
Unknown status	`NCT01348906` - Intermittent Normoxia Reduces Myocardial Reperfusion Injury	N/A
Completed	`NCT04420897` - The Effect of Intraoperative Arterial Oxygen Pressures on Early Post-Operative Patient and Graft Survival in Living Donor Kidney Transplantation
Completed	`NCT03930979` - The Effect of Hyperoxia on Cardiac Output
Not yet recruiting	`NCT06326372` - The Effect of Intraoperative Hyperoxemia on Postoperative Delirium in Geriatric Patients
Recruiting	`NCT05412810` - Oxidative Lipidomic Biomarkers During Mechanical Ventilation in Critically Ill Patients (OXY-BAL).
Completed	`NCT05807815` - The Effectiveness of the Use of Oxygen Reserve Index in Preventing Hyperoxia in the Intensive Care Unit.	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.